Rhopressa (netarsudil ophthalmic solution 0.02%) by Aerie Pharmaceuticals Inc., proposed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Read MoreJUL 19 DODAC
Valeant’s brodalumab for plaque psoriasis
Read MoreJUL 19 DODAC
Valeant’s brodalumab for plaque psoriasis
Read MoreJUL 19 DODAC
Valeant’s brodalumab for plaque psoriasis
Read MoreMAR 9 DODAC
1) Kythera's deoxycholic acid injection 2) Pediatric development of atopic dermatitis drugs
Read MoreMAR 9 DODAC
1) Kythera's deoxycholic acid injection 2) Pediatric development of atopic dermatitis drugs
Read MoreFEB 24 DODAC
Avedro’s VibeX/KXL System to Treat Rare Corneal Disorder Following LASIK
Read MoreFEB 24 DODAC
Avedro’s VibeX/KXL System to Treat Rare Corneal Disorder Following LASIK
Read MoreFEB 24 DODAC
Avedro’s VibeX/KXL System to Treat Rare Corneal Disorder Following LASIK
Read MoreMAR 9 DODAC
1) Kythera's deoxycholic acid injection 2) Pediatric development of atopic dermatitis drugs
Read MoreOCT 20 DODAC
Novartis' secukinumab for psoriasis
Read MoreOCT 20 DODAC
Novartis' secukinumab for psoriasis
Read MoreOCT 20 DODAC
Novartis' secukinumab for psoriasis
Read More